• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

定量评估调查 COVID-19 负担所需的流行病学参数。

A quantitative assessment of epidemiological parameters required to investigate COVID-19 burden.

机构信息

Bruno Kessler Foundation, Trento, Italy.

Bruno Kessler Foundation, Trento, Italy; Department of Mathematics, Computer Science and Physics, University of Udine, Udine, Italy.

出版信息

Epidemics. 2021 Dec;37:100530. doi: 10.1016/j.epidem.2021.100530. Epub 2021 Nov 17.

DOI:10.1016/j.epidem.2021.100530
PMID:34826786
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8595250/
Abstract

Solid estimates describing the clinical course of SARS-CoV-2 infections are still lacking due to under-ascertainment of asymptomatic and mild-disease cases. In this work, we quantify age-specific probabilities of transitions between stages defining the natural history of SARS-CoV-2 infection from 1965 SARS-CoV-2 positive individuals identified in Italy between March and April 2020 among contacts of confirmed cases. Infected contacts of cases were confirmed via RT-PCR tests as part of contact tracing activities or retrospectively via IgG serological tests and followed-up for symptoms and clinical outcomes. In addition, we provide estimates of time intervals between key events defining the clinical progression of cases as obtained from a larger sample, consisting of 95,371 infections ascertained between February and July 2020. We found that being older than 60 years of age was associated with a 39.9% (95%CI: 36.2-43.6%) likelihood of developing respiratory symptoms or fever ≥ 37.5 °C after SARS-CoV-2 infection; the 22.3% (95%CI: 19.3-25.6%) of the infections in this age group required hospital care and the 1% (95%CI: 0.4-2.1%) were admitted to an intensive care unit (ICU). The corresponding proportions in individuals younger than 60 years were estimated at 27.9% (95%CI: 25.4-30.4%), 8.8% (95%CI: 7.3-10.5%) and 0.4% (95%CI: 0.1-0.9%), respectively. The infection fatality ratio (IFR) ranged from 0.2% (95%CI: 0.0-0.6%) in individuals younger than 60 years to 12.3% (95%CI: 6.9-19.7%) for those aged 80 years or more; the case fatality ratio (CFR) in these two age classes was 0.6% (95%CI: 0.1-2%) and 19.2% (95%CI: 10.9-30.1%), respectively. The median length of stay in hospital was 10 (IQR: 3-21) days; the length of stay in ICU was 11 (IQR: 6-19) days. The obtained estimates provide insights into the epidemiology of COVID-19 and could be instrumental to refine mathematical modeling work supporting public health decisions.

摘要

由于对无症状和轻症病例的确诊不足,目前仍缺乏描述 SARS-CoV-2 感染临床过程的可靠数据。本研究通过对 2020 年 3 月至 4 月间意大利确诊病例的接触者中 1965 名 SARS-CoV-2 阳性个体进行回顾性 IgG 血清学检测或实时逆转录聚合酶链反应(RT-PCR)检测,定量分析了年龄特异性的 SARS-CoV-2 感染自然史各阶段之间的转移概率。接触者感染后,通过接触者追踪活动或通过 RT-PCR 检测作为确诊病例的一部分进行确认,并对症状和临床结果进行随访。此外,我们还提供了从包含 2020 年 2 月至 7 月期间确诊的 95371 例感染病例的更大样本中获得的关键临床事件时间间隔的估计值。我们发现,与 60 岁以下的人相比,60 岁以上的人感染 SARS-CoV-2 后出现呼吸道症状或发热≥37.5°C 的可能性高 39.9%(95%CI:36.2-43.6%);该年龄组中 22.3%(95%CI:19.3-25.6%)的感染者需要住院治疗,1%(95%CI:0.4-2.1%)的感染者需要入住重症监护病房(ICU)。60 岁以下人群的相应比例估计为 27.9%(95%CI:25.4-30.4%)、8.8%(95%CI:7.3-10.5%)和 0.4%(95%CI:0.1-0.9%)。60 岁以下人群的感染病死率(IFR)为 0.2%(95%CI:0.0-0.6%),80 岁及以上人群的 IFR 为 12.3%(95%CI:6.9-19.7%);这两个年龄组的病例病死率(CFR)分别为 0.6%(95%CI:0.1-2%)和 19.2%(95%CI:10.9-30.1%)。住院中位时间为 10 天(IQR:3-21),入住 ICU 的中位时间为 11 天(IQR:6-19)。获得的估计值提供了对 COVID-19 流行病学的深入了解,并有助于完善支持公共卫生决策的数学建模工作。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/932c/8595250/45380d41fbb1/gr3_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/932c/8595250/aea1039c33e3/gr1_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/932c/8595250/2d7e485130ad/gr2_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/932c/8595250/45380d41fbb1/gr3_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/932c/8595250/aea1039c33e3/gr1_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/932c/8595250/2d7e485130ad/gr2_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/932c/8595250/45380d41fbb1/gr3_lrg.jpg

相似文献

1
A quantitative assessment of epidemiological parameters required to investigate COVID-19 burden.定量评估调查 COVID-19 负担所需的流行病学参数。
Epidemics. 2021 Dec;37:100530. doi: 10.1016/j.epidem.2021.100530. Epub 2021 Nov 17.
2
Association of Age With Likelihood of Developing Symptoms and Critical Disease Among Close Contacts Exposed to Patients With Confirmed SARS-CoV-2 Infection in Italy.意大利接触确诊 SARS-CoV-2 感染患者的密切接触者中,年龄与出现症状和重症疾病的可能性之间的关系。
JAMA Netw Open. 2021 Mar 1;4(3):e211085. doi: 10.1001/jamanetworkopen.2021.1085.
3
Baseline Characteristics and Outcomes of 1591 Patients Infected With SARS-CoV-2 Admitted to ICUs of the Lombardy Region, Italy.意大利伦巴第地区 1591 名 ICU 收治的 SARS-CoV-2 感染患者的基线特征和结局。
JAMA. 2020 Apr 28;323(16):1574-1581. doi: 10.1001/jama.2020.5394.
4
A prospective, randomized, single-blinded, crossover trial to investigate the effect of a wearable device in addition to a daily symptom diary for the remote early detection of SARS-CoV-2 infections (COVID-RED): a structured summary of a study protocol for a randomized controlled trial.一项前瞻性、随机、单盲、交叉试验,旨在研究可穿戴设备对远程早期检测 SARS-CoV-2 感染(COVID-RED)的影响:一项随机对照试验研究方案的结构化总结。
Trials. 2021 Jun 22;22(1):412. doi: 10.1186/s13063-021-05241-5.
5
A prospective, randomized, single-blinded, crossover trial to investigate the effect of a wearable device in addition to a daily symptom diary for the Remote Early Detection of SARS-CoV-2 infections (COVID-RED): a structured summary of a study protocol for a randomized controlled trial.一项前瞻性、随机、单盲、交叉试验,旨在研究可穿戴设备对 SARS-CoV-2 感染(COVID-RED)的远程早期检测的影响:一项随机对照试验研究方案的结构化总结。
Trials. 2021 Oct 11;22(1):694. doi: 10.1186/s13063-021-05643-5.
6
Effectiveness and cost-effectiveness of four different strategies for SARS-CoV-2 surveillance in the general population (CoV-Surv Study): a structured summary of a study protocol for a cluster-randomised, two-factorial controlled trial.在普通人群中进行 SARS-CoV-2 监测的四种不同策略的有效性和成本效益(CoV-Surv 研究):一项关于集群随机、双因素对照试验的研究方案的结构化总结。
Trials. 2021 Jan 8;22(1):39. doi: 10.1186/s13063-020-04982-z.
7
Estimation of SARS-CoV-2 mortality during the early stages of an epidemic: A modeling study in Hubei, China, and six regions in Europe.估算疫情早期 SARS-CoV-2 的死亡率:在中国湖北和欧洲六个地区的建模研究。
PLoS Med. 2020 Jul 28;17(7):e1003189. doi: 10.1371/journal.pmed.1003189. eCollection 2020 Jul.
8
SARS-CoV-2 seroprevalence and transmission risk factors among high-risk close contacts: a retrospective cohort study.SARS-CoV-2 血清流行率和高危密切接触者的传播风险因素:一项回顾性队列研究。
Lancet Infect Dis. 2021 Mar;21(3):333-343. doi: 10.1016/S1473-3099(20)30833-1. Epub 2020 Nov 2.
9
Estimating the Proportion of Asymptomatic COVID-19 Cases in an Italian Region with Intermediate Incidence during the First Pandemic Wave: An Observational Retrospective Study.估算意大利某地区第一波大流行期间中度发病率下无症状 COVID-19 病例的比例:一项观察性回顾性研究。
Biomed Res Int. 2022 Jan 6;2022:3401566. doi: 10.1155/2022/3401566. eCollection 2022.
10
Factors Associated With Using the COVID-19 Mobile Contact-Tracing App Among Individuals Diagnosed With SARS-CoV-2 in Amsterdam, the Netherlands: Observational Study.与在荷兰阿姆斯特丹被诊断患有 SARS-CoV-2 的个体使用 COVID-19 移动接触者追踪应用程序相关的因素:观察性研究。
JMIR Mhealth Uhealth. 2022 Aug 24;10(8):e31099. doi: 10.2196/31099.

引用本文的文献

1
Estimating SARS-CoV-2 infections and associated changes in COVID-19 severity and fatality.估算 SARS-CoV-2 感染以及 COVID-19 严重程度和病死率的相关变化。
Influenza Other Respir Viruses. 2023 Aug 16;17(8):e13181. doi: 10.1111/irv.13181. eCollection 2023 Aug.
2
Priority age targets for COVID-19 vaccination in Ethiopia under limited vaccine supply.在疫苗供应有限的情况下,埃塞俄比亚 COVID-19 疫苗接种的优先年龄目标。
Sci Rep. 2023 Apr 5;13(1):5586. doi: 10.1038/s41598-023-32501-y.
3
Do pathogens always evolve to be less virulent? The virulence-transmission trade-off in light of the COVID-19 pandemic.

本文引用的文献

1
Estimating the extent of asymptomatic COVID-19 and its potential for community transmission: Systematic review and meta-analysis.评估无症状新冠病毒感染的程度及其社区传播潜力:系统评价与荟萃分析。
J Assoc Med Microbiol Infect Dis Can. 2020 Dec 31;5(4):223-234. doi: 10.3138/jammi-2020-0030. eCollection 2020 Dec.
2
The early phase of the COVID-19 epidemic in Lombardy, Italy.意大利伦巴第大区的 COVID-19 疫情早期阶段。
Epidemics. 2021 Dec;37:100528. doi: 10.1016/j.epidem.2021.100528. Epub 2021 Nov 20.
3
Pressure on the Health-Care System and Intensive Care Utilization During the COVID-19 Outbreak in the Lombardy Region of Italy: A Retrospective Observational Study in 43,538 Hospitalized Patients.
病原体是否总是朝着毒力降低的方向进化?基于 COVID-19 大流行的病毒毒力-传播权衡。
Biol Futur. 2023 Jun;74(1-2):69-80. doi: 10.1007/s42977-023-00159-2. Epub 2023 Mar 31.
4
A Markovian model for the spread of the SARS-CoV-2 virus.一种用于严重急性呼吸综合征冠状病毒2(SARS-CoV-2)病毒传播的马尔可夫模型。
Automatica (Oxf). 2023 May;151:110921. doi: 10.1016/j.automatica.2023.110921. Epub 2023 Feb 15.
5
Model-based evaluation of alternative reactive class closure strategies against COVID-19.基于模型的 COVID-19 反应性类别关闭策略替代方案评估。
Nat Commun. 2022 Jan 14;13(1):322. doi: 10.1038/s41467-021-27939-5.
6
Digital Surveillance Through an Online Decision Support Tool for COVID-19 Over One Year of the Pandemic in Italy: Observational Study.数字监控:意大利大流行一年期间通过在线决策支持工具对 COVID-19 的观察性研究。
J Med Internet Res. 2021 Aug 13;23(8):e29556. doi: 10.2196/29556.
7
Model-based evaluation of alternative reactive class closure strategies against COVID-19.基于模型的针对新型冠状病毒肺炎的替代反应性类别封闭策略评估
medRxiv. 2021 Apr 23:2021.04.18.21255683. doi: 10.1101/2021.04.18.21255683.
意大利伦巴第地区 COVID-19 爆发期间医疗系统压力和重症监护利用情况:43538 例住院患者的回顾性观察研究。
Am J Epidemiol. 2022 Jan 1;191(1):137-146. doi: 10.1093/aje/kwab252.
4
Modeling the interplay between demography, social contact patterns, and SARS-CoV-2 transmission in the South West Shewa Zone of Oromia Region, Ethiopia.在埃塞俄比亚奥罗米亚地区西南绍瓦地区,对人口统计学、社会接触模式和 SARS-CoV-2 传播之间的相互作用进行建模。
BMC Med. 2021 Apr 9;19(1):89. doi: 10.1186/s12916-021-01967-w.
5
Assessing transmissibility of SARS-CoV-2 lineage B.1.1.7 in England.评估 SARS-CoV-2 谱系 B.1.1.7 在英国的传播能力。
Nature. 2021 May;593(7858):266-269. doi: 10.1038/s41586-021-03470-x. Epub 2021 Mar 25.
6
Modelling COVID-19.新冠病毒病建模
Nat Rev Phys. 2020;2(6):279-281. doi: 10.1038/s42254-020-0178-4. Epub 2020 May 6.
7
Increased mortality in community-tested cases of SARS-CoV-2 lineage B.1.1.7.社区检出的 SARS-CoV-2 谱系 B.1.1.7 病例死亡率增加。
Nature. 2021 May;593(7858):270-274. doi: 10.1038/s41586-021-03426-1. Epub 2021 Mar 15.
8
Association of Age With Likelihood of Developing Symptoms and Critical Disease Among Close Contacts Exposed to Patients With Confirmed SARS-CoV-2 Infection in Italy.意大利接触确诊 SARS-CoV-2 感染患者的密切接触者中,年龄与出现症状和重症疾病的可能性之间的关系。
JAMA Netw Open. 2021 Mar 1;4(3):e211085. doi: 10.1001/jamanetworkopen.2021.1085.
9
Retrospective analysis of the Italian exit strategy from COVID-19 lockdown.回顾性分析意大利从 COVID-19 封锁中退出的策略。
Proc Natl Acad Sci U S A. 2021 Jan 26;118(4). doi: 10.1073/pnas.2019617118.
10
Epidemiological characteristics of COVID-19 cases and estimates of the reproductive numbers 1 month into the epidemic, Italy, 28 January to 31 March 2020.2020 年 1 月 28 日至 3 月 31 日意大利新冠疫情流行 1 个月时的病例流行病学特征及繁殖数估计
Euro Surveill. 2020 Dec;25(49). doi: 10.2807/1560-7917.ES.2020.25.49.2000790.